tiprankstipranks

Analyst Profile

Followed by 109 followers
.
Scott Henry

Scott Henry

Roth Capital
Wall Street Analyst
#3,559 out of 7,961 Wall Street Analysts
#8,138 out of 22,230 experts

Success Rate

41%
170 out of 415 transactions made a profit

Average Return

+0.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Scott Henry's trades since 2009 and holding each position for 1 Year would result in 40.96% of your transactions generating a profit, with an average return of 0.6% per rating.

Stock Rating Distribution

578Ratings
83.22% Buy
16.78% Hold
0.00% Sell
Distribution of Scott Henry's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
CanadaCanadian Market

Best Rating

Stock:
Cormedix Inc.
(CRMD)
Rating:Buy
Date:Dec 08, 2014 - May 06, 2015
Return:+467.60%
The most profitable rating made by Scott Henry

Scott Henry's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Alkermes
Apr 03, 2009
Hold
Downgraded
$14.00
(-37.28% Downside)
1Ratings
0.00%
SNTS
Santarus
Nov 18, 2013
Hold
Downgraded
5Ratings
50%
+7.65%
CHTP
Chelsea Therapeutics
May 21, 2014
Hold
Downgraded
1Ratings
0.00%
Windtree Therapeutics
Nov 06, 2014
Buy
Reiterated
$5.00
(1573.36% Upside)
3Ratings
0%
-73.57%
SLXP
Salix
Nov 07, 2014
Hold
Downgraded
5Ratings
25%
+1.17%
ALXA
Alexza Pharmaceuticals
Mar 27, 2015
Hold
Reiterated
6Ratings
0%
-15.15%
KIN
Kindred Biosciences
Aug 13, 2015
Hold
Reiterated
4Ratings
0.00%
INSV
Insite Vision
Aug 18, 2015
Hold
Reiterated
4Ratings
50%
+1.00%
Interpace Diagnostics Group
Aug 24, 2015
Buy
Reiterated
$3.00
(57.89% Upside)
4Ratings
0%
-52.35%
SGYPQ
Synergy Pharmaceuticals Inc
Oct 29, 2015
Buy
Assigned
3Ratings
67%
+63.83%
List of latest recommendations made by Scott Henry. Click to expand and see Scott Henry's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >